Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Arena Pharmaceuticals, Inc.
*MAILING ADDRESS
6154 Nancy Ridge Drive
*CITY
San Diego
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92121
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
pharmaceutical preparations for human use; biological preparations for human use; pharmaceutical preparations and pharmaceutical compounds for
the treatment of disorders of the central nervous system; biological preparations for the treatment of disorders of the central nervous system
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and
biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and
post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, biologics, clinical trials and post-market
trials; research and development services in the fields of pharmaceuticals, biologics and biotechnology; scientific research and development; laboratory research, screening, evaluation, development
and clinical testing of therapeutic compounds; scientific research, studies, and development in the field of pharmaceuticals and biologics; scientific research and development, namely, pharmaceutical
discovery, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation
development
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Providing medical information
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Allison Strickland Ricketts
ATTORNEY DOCKET NUMBER
ARPI 2009652
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
STREET
151 West 42nd St., 17th Fl
CITY
New York
STATE
New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
10036
PHONE
212-813-5967
EMAIL ADDRESS
ricketts-docket@fzlz.com
OTHER APPOINTED ATTORNEY
Lawrence E. Apolzon, Andrew N. Fredbeck, Nancy Sabarra, Karen Lim, Charles T.J. Weigell, Ashford Tucker, Tamar Niv Bessinger
CORRESPONDENCE INFORMATION
NAME
Allison Strickland Ricketts
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
ricketts-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEES DUE
825
*TOTAL FEES PAID
825
SIGNATURE INFORMATION
SIGNATURE
/Shannon K. Carter/
SIGNATORY'S NAME
Shannon K. Carter
SIGNATORY'S POSITION
VP, Intellectual Property
SIGNATORY'S PHONE NUMBER
858-453-7200
DATE SIGNED
10/02/2020
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:90232096
Filing Date:10/02/2020
To the Commissioner for Trademarks:
MARK: LONGBOARD (Standard Characters, see mark)
The literal element of the mark consists of LONGBOARD. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Arena Pharmaceuticals, Inc., a corporation of Delaware, having an address of
6154 Nancy Ridge Drive
San Diego, California 92121
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: pharmaceutical preparations for human use; biological preparations for human use; pharmaceutical preparations and pharmaceutical compounds for the treatment of
disorders of the central nervous system; biological preparations for the treatment of disorders of the central nervous system
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical,
biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials;
pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, biologics, clinical trials and post-market trials; research and
development services in the fields of pharmaceuticals, biologics and biotechnology; scientific research and development; laboratory research, screening, evaluation, development and clinical testing
of therapeutic compounds; scientific research, studies, and development in the field of pharmaceuticals and biologics; scientific research and development, namely, pharmaceutical discovery, process
development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation development
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Providing medical information
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Allison Strickland Ricketts. Other appointed attorneys are Lawrence E. Apolzon, Andrew N. Fredbeck, Nancy Sabarra, Karen Lim, Charles T.J. Weigell,
Ashford Tucker, Tamar Niv Bessinger. Allison Strickland Ricketts of FROSS ZELNICK LEHRMAN & ZISSU, P.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and
the attorney(s) is located at
151 West 42nd St., 17th Fl
New York, New York 10036
United States
212-813-5967(phone)
ricketts-docket@fzlz.com
The docket/reference number is ARPI 2009652.
Allison Strickland Ricketts submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia,
or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Allison Strickland Ricketts
PRIMARY EMAIL FOR CORRESPONDENCE: ricketts-docket@fzlz.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /Shannon K. Carter/ Date: 10/02/2020
Signatory's Name: Shannon K. Carter
Signatory's Position: VP, Intellectual Property
Payment Sale Number: 90232096
Payment Accounting Date: 10/02/2020
Serial Number: 90232096
Internet Transmission Date: Fri Oct 02 13:31:28 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2020100213312803
6382-90232096-750dc64ee91479d8fd544e711c
bd1c17297448c27d2cf97881b986fa7281194c-D
A-31273517-20201001095809893320